US FDA adds strongest warning to Sarepta gene therapy after fatal liver injuries-March 2024-www.financetom.com

US FDA adds strongest warning to Sarepta gene therapy after fatal liver injuries

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA adds strongest warning to Sarepta gene therapy after fatal liver injuries

Nov 14, 2025 11:24 AM

Nov 14 (Reuters) - The U.S. Food and Drug Administration

said on Friday it approved new labeling for Sarepta

Therapeutics' ( SRPT ) gene therapy Elevidys that includes its

most serious safety warning and restricts use of the treatment

to walking patients 4 years of age and older with Duchenne

muscular dystrophy.

Previous page： Gitlab Insider Sold Shares Worth $32,714,896, According to a Recent SEC Filing Next page： CompoSecure Plans to Spin-Off Resolute Holdings; Shares Jump After-Hours

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Gitlab Insider Sold Shares Worth $32,714,896, According to a Recent SEC Filing

Dec 30, 2024

05:17 PM EST, 12/30/2024 (MT Newswires) -- Matthew Jacobson, Director, on December 26, 2024, sold 547,779 shares in Gitlab ( GTLB ) for $32,714,896. Following the Form 4 filing with the SEC, Jacobson has control over a total of 4,753,830 shares of the company, with 551,618 shares held directly and 4,202,212 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1653482/000095017024141192/xslF345X05/ownership.xml ...

CompoSecure Plans to Spin-Off Resolute Holdings; Shares Jump After-Hours

Dec 30, 2024

05:17 PM EST, 12/30/2024 (MT Newswires) -- CompoSecure ( CMPO ) said late Monday it plans to spin off its newly-formed Resolute Holdings Management unit to accelerate value enhancing acquisitions. The investment team at CompoSecure ( CMPO ) will move to Resolute after the spin-off, the firm said, adding that it will enter into a management agreement with Resolute. The...

Dover Unit Opens Propane Testing Facility in Sweden

Dec 30, 2024

05:16 PM EST, 12/30/2024 (MT Newswires) -- Dover (DOV) unit SWEP said late Monday it opened a rig for propane testing at a research and development center in Landskrona, Sweden. The company said the new rig will aid in developing brazed plate heat exchangers optimized for systems using natural refrigerants, adding that it is designed to accommodate a wide propane...

Verastem's Ovarian Cancer Drug Application Accepted by FDA, Gets Priority Review

Dec 30, 2024

05:17 PM EST, 12/30/2024 (MT Newswires) -- Verastem ( VSTM ) said Monday that the US Food and Drug Administration accepted for review the new drug application for avutometinib in combination with defactinib for the treatment of patients with recurrent low-grade serous ovarian cancer that received at least one systemic treatment and have KRAS mutation. The FDA granted priority review...